Patent · US Active

Interleukin-1 alpha antibodies and methods of use

US8388956B2 · kind B2 · utility

13Cited by
3References
1Claims
0Family size

Assignee

Inventor

Key dates

Filing dateSep 2, 2011
Grant dateMar 5, 2013
Priority date—
Expiry dateSep 2, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/545
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Fully human monoclonal Abs includes (i) an antigen-binding variable region that exhibits very high binding affinity for IL-1α and (ii) a constant region that is effective at both activating the complement system though C1q binding and binding to several different Fc receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.